Polyphenols counteract tumor cell chemoresistance conferred by multidrug resistance proteins
Krystyna Michalak and Olga Wesołowska

Editorial: Natural Polyphenols Properties: Chemopreventive and Chemosensitizing Activities
Dominique Delmas and Jianbo Xiao

Editorial: Natural Compounds as Cancer Chemopreventive and Chemotherapeutic Agents: Insights Gained from Mechanistic and Pharmacologic Studies
Bao Ting Zhu

Cancer Prevention with Promising Natural Products: Mechanisms of Action and Molecular Targets
Poyil Pratheeshkumar, Chakkenchath Sreekala, Zhuo Zhang, Amit Budhraja, Songze Ding, Young-Ok Son, Xin Wang, Andrew Hitron, Kim Hyun-Jung, , Lei Wang, Jeong-Chae Lee and Xianglin Shi

Chemoprevention of Breast Cancer By Dietary Compounds
Aditi Shirish Vadodkar, Suman Suman, Rajkumar Lakshmanaswamy and Chendil Damodaran

Unifying Mechanisms of Action of the Anticancer Activities of Triterpenoids and Synthetic Analogs
Stephen H. Safe, Paul L. Prather, Lisa K. Brents, Gayathri Chadalapaka and Indira Jutooru

Anti-cancer and Other Bioactivities of Korean Angelica gigas Nakai (AGN) and Its Major Pyranocoumarin Compounds
Jinhui Zhang, Li Li, Cheng Jiang, Chengguo Xing, Sung-Hoon Kim and Junxuan Lü

The Cancer Preventive Effects of Edible Mushrooms
Tongtong Xu, Robert B. Beelman and Joshua D. Lambert

Bioavailability and Pharmacokinetics of Genistein: Mechanistic Studies on its ADME
Zhen Yang, Kaustubh Kulkarni, Wei Zhu and Ming Hu

Plants against Cancer: A Review on Natural Phytochemicals in Preventing and Treating Cancers and Their Drug ability
Hu Wang, Tin Oo Khor, Limin Shu, Zhengyuen Su, Francisco Fuentes and Jong-Hun Lee

Developing Phytoestrogens for Breast Cancer Prevention
Mandy M. Liu, Ying Huang and Jeffrey Wang

Prevention of Colitis-associated Cancer: Natural Compounds that target the IL-6 Soluble Receptor
Cate Moriasi, Dharmalingam Subramaniam, Shanjana Awasthi, Satish Ramalingam and Shrikant Anant

The Nuclear Orphan Receptors Nr4a As Therapeutic Target In Cancer Therapy
Alexander J. A. Deutsch, Hannes Angerer, Tamara E. Fuchs and Peter Neumeister

Calculation of Molecular Features with Apparent Impact on Both Activity Of Mutagens And Activity Of Anticancer Agents
Andrey A. Toropov,  Alla P. Toropova,  Emilio Benfenati, Giusippina Gini,  Danuta Leszczynska and Jerzy Leszczynski

The Role of Peroxisome Proliferator-Activated Receptor-γ in Breast Cancer
Ioly Kotta-Loizou, Constantinos Giaginis and Stamatios Theocharis

Targeted therapy for advanced urothelial cancer of the bladder: Where do we stand?
Zhaowei Zhu, Zhoujun Shen and Chen Xu

Experimental and Theoretical Advances in Functional Understanding of Flavonoids as Anti-Tumor Agents
B. Venkata Babu, Naveen Kumar Konduru, Waro Nakanishi, Satoko Hayashi, Naseem Ahmed and Petar M. Mitrasinovic

Platinum Compounds: A Hope for Future Cancer Chemotherapy
Imran Ali, Waseem A. Wani, Kishwar Saleem and Ashanul Haque

Treatment Directed To Signalling Molecules In Patients With Advanced Differentiated Thyroid Cancer
José Manuel Gómez Sáez

Metformin: A Rising Star to Fight the Mesenchymal Epithelial Transition In Oncology
Guislaine Barrière, Michel Tartary and Michel Rigaud

JAK2 Inhibitors for Myelofibrosis: Why Are They Effective in Patients With and Without JAK2V617F Mutation?
Fabio P S Santos and Srdan Verstovsek

Cytoskeletal Alterations That Confer Resistance to Anti-Tubulin Chemotherapeutics
Arun Kanakkanthara, Paul H. Teesdale-Spittle and John H. Miller

Anticancer Activity of New Haloalkyl Camptothecin Esters against Human Cancer Cell Lines and Human Tumor Xenografts Grown in Nude Mice
Zhisong Cao, John Mendoza, Anthony Kozielski, Xing Liu, Albert DeJesus, Yang Wang, Chang-Guo Zhan, Dana Vardeman and Beppino Giovanella

A Novel Anti-tumor Inhibitor Identified by Virtual Screen with PLK1 Structure and Zebrafish Assay
Jing Lu, Hua Meng, David Schoenfeld, Shengchang Xin, Chao Che, Ruibin Yan, Hanbing Zhong, Song Li and Shuo Lin

Carbon nanotubes in the diagnosis and treatment of malignant melanoma
Naghmeh Naderi, Seyed Y. Madani, Afshin Mosahebi and Alexander M. Seifalian

New Insight into P-Glycoprotein as a Drug Target
Albert Breier, Lenka Gibalova, Mario Seres, Miroslav Barancik and Zdenka Sulova

ALK inhibitors: a new targeted therapy in the treatment of advanced NSCLC
Casaluce Francesca, Sgambato Assunta, Maione Paolo, Rossi Antonio, Rossi Emanuela, Napolitano Alba, Palazzolo Giovanni, Bareschino Marianna, Schettino Clorinda, Sacco Paola Chiara, Ciardiello Fortunato and Gridelli Cesare

Synthesis and Biological Evaluation of Azaindirubin Analogues Bearing One or Two 7-Azaindole Moieties
Zhao-Hui Wang, Xiao-Long Jiang, Xiao-Wen Xue, Yong Li, Jing-jing Li, Chen-Yuan Liang, Jin Kang and Qi-Zheng Yao

Combinations of Plant Polyphenols & AntiâCancer Molecules: A Novel Treatment Strategy for Cancer Chemotherapy
Aarti Mohan, Shridhar Narayanan, Swaminathan Sethuraman and Uma Maheswari Krishnan

Tyroservatide Therapy for Tumor Invasion and Metastasis of Human Ovarian Carcinoma and Colon Carcinoma
Lanlan Wang, Xuchun Che, Jinping Li, Junqiang Lv, Chunlei Zhou, Song Wang, Zhifeng Zhu, Li Wang, Gang Lin, Rong Lu and Zhi Yao